You just read:

Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease

News provided by

Aquinnah Pharmaceuticals

Apr 25, 2017, 08:00 ET